FDAnews
www.fdanews.com/articles/213056-three-warning-letters-for-amazon-in-2023-company-named-in-five-others

Three Warning Letters for Amazon in 2023, Company Named in Five Others

January 2, 2024

Amazon was hit with its third FDA warning letter of the year last week, this time for selling unapproved and incorrectly labeled products that contain the active ingredient in erectile dysfunction (ED) drugs Cialis and Viagra.

Just a month earlier, the mega online retailer got a warning letter for selling unapproved pink eye remedies. And in August, Amazon was slapped with a warning letter for selling unapproved products to treat molluscum contagiosum, an infection caused by a poxvirus that results in bumps on the skin.

Amazon was also named in five other warning letters this year aimed at companies selling unapproved and mislabeled drugs via Amazon’s site.

Read the December warning letter here. Read the November warning letter here. Read the August warning letter here.

Read the five warning letters that also mention Amazon here, here, here, here and here.

To read the whole story, click here to subscribe.

Related Topics